Podcast: Treatment Intensification in mCSPC – The Nurse Perspective
Podcast: Treatment Intensification in mCSPC – The Nurse Perspective
Listen as GU oncology nurses share their views in this clinical update podcast
Listen as GU oncology nurses share their views in this clinical update podcast
Brenda Martone, Jennifer Sutton
In this podcast, oncology nurses Brenda Martone and Jennifer Sutton discuss how to use data to select the most appropriate treatments for patients with metastatic castration-sensitive prostate cancer. They also share the importance of being able to explain these clinical decisions to patients and reassure them that earlier intensive treatment can prolong overall survival without seriously impacting quality of life.
Brenda Martone
Oncology Nurse Practitioner
Northwestern Medicine
United States (US)
Jennifer Sutton
Director of Nursing & Administration
Carolina Urologic Research Center
United States (US)
Podcast | 
19 min
|
Jun 2023
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Clinical Takeaways
-
Treatment intensification with triplet therapy (ADT plus NHA plus docetaxel) should be the new standard of care for high-risk, high-volume, mCSPC patients who are fit for chemotherapy
-
Early treatment intensification should be considered for these patients whilst they are still well enough to tolerate intensive treatment
-
When determining which triplet regimen would be the most appropriate for your patient, it is important to consider the patient's co-morbidities, risk profile and potential drug-drug interactions
-
The nurse has a key role in communicating the benefits and risks of different triplet regimens to the patients
-
Patient education on potential side effects and early reporting of them is essential to optimise patient outcomes
This educational podcast is endorsed by 
This educational programme is supported by an Independent Medical Education Grant from Bayer
GU NURSES CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from AstraZeneca, Bayer and Eisai Europe Limited.
Other programmes of interest
2 min
Other programmes developed by Brenda Martone
Brenda Martone
Oncology Nurse Practitioner
Northwestern Medicine
United States (US)
Other programmes developed by Jennifer Sutton
Jennifer Sutton
Director of Nursing & Administration
Carolina Urologic Research Center
United States (US)
